Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA
hsa-miR-371a-3p
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Prognosis
Upstream regulatory factor
Not available
Downstream target
Not available
Differential expression in
recurrence vs. nonrecurrence
Up
Cancer name
Germ Cell Tumour of Testis
Alias
Testicular Cancer
Cancer site
Testicular
Recurrence type
Recurrence
Overall survival rate of patients with
high ncRNA expression
Down
ncRNA differential expression in
cancer
patients vs. health people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
Recurrence patients
Not available
Recurrence patients male:female
Not available
Recurrence patients age range
Not available
Recurrence mean age
Not available
Sites of recurrence
Not available
Patients without recurrence
Not available
Patients without recurrence male:female
Patients without recurrence age range
Not available
Patients without recurrence mean age
Not available
PMID
Description
MiR-371a-3p levels in serum samples with proven disease recurrence were 13.65 fold higher than levels from the same patients without evidence of disease (p = 0.014).
Tissue resource
serum samples from patients with TGCT recurrence and no evidence of TGCT recurrence
Experiment
qRT-PCR
Institute
the Medical University of Graz
Country
Austria
Continent
Australia
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.